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Abstract
Background: Two of the most important pathogens contributing to the global rise in antimicrobial resistance
(AMR) are Klebsiella pneumoniae and Enterobacter cloacae. Despite this, most of our knowledge about the changing
patterns of disease caused by these two pathogens is based on studies with limited timeframes that provide few
insights into their population dynamics or the dynamics in AMR elements that they can carry.
Results: We investigate the population dynamics of two priority AMR pathogens over 7 years between 2007 and
2012 in a major UK hospital, spanning changes made to UK national antimicrobial prescribing policy in 2007.
Between 2006 and 2012, K. pneumoniae showed epidemiological cycles of multi-drug-resistant (MDR) lineages
being replaced approximately every 2 years. This contrasted E. cloacae where there was no temporally changing
pattern, but a continuous presence of the mixed population.
Conclusions: The differing patterns of clonal replacement and acquisition of mobile elements shows that the flux
in the K. pneumoniae population was linked to the introduction of globally recognized MDR clones carrying drug
resistance markers on mobile elements. However, E. cloacae carries a chromosomally encoded ampC conferring
resistance to front-line treatments and shows that MDR plasmid acquisition in E. cloacae was not indicative of
success in the hospital. This led to markedly different dynamics in the AMR populations of these two pathogens
and shows that the mechanism of the resistance and its location in the genome or mobile elements is crucial to
predict population dynamics of opportunistic pathogens in clinical settings.
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Background
Since the early 2000s, successive pandemics of bacterial
resistance, first- to third-generation cephalosporins and
then to carbapenems, have eroded the utility of our most
useful antimicrobials (the beta-lactams). Klebsiella pneu-
moniae and Enterobacter cloacae are amongst the pri-
mary threats to human health due to the range of
hospital-acquired infections (HAIs) that they can cause
and their potential for becoming multidrug-resistant [1].
Through the increase of antimicrobial resistance, consid-
erable research has focused on understanding opportun-
istic pathogens and especially the different mechanisms
conferring AMR.
The K. pneumoniae genome encodes for an ancestrally
acquired penicillinase leaving it readily treatable with
cephalosporins and other antimicrobials. The wide-
spread acquisition of mobile CTX-M and other
extended-spectrum beta-lactamases (ESBLs) encoded on
conjugative (transferable) plasmids [2, 3] has been a
major driver in the success of K. pneumoniae as hospital
pathogen. E. cloacae carry a chromosomally encoded
AmpC beta-lactamase which has a wide spectrum of ac-
tivity conferring intrinsic resistance to many front-line
treatment options including penicillins, penicillin-
penicillinase inhibitor combinations, and (when ampC
becomes derepressed) third-generation cephalosporins,
making it a major contributor towards intrinsic resist-
ance for Enterobacter spp.
Both K. pneumoniae and E. cloacae remain largely sus-
ceptible to other important groups of antimicrobials in
the UK [4]. This includes key drugs such as fluoroquino-
lones, where resistance can derive from acquired genes
but is often caused by chromosomal mutations of the
enzymes encoded by gyrA and parC. Other examples of
gene acquisitions driving resistance include the amino-
glycosides [5, 6] and other antimicrobials such as chlor-
amphenicol or tetracycline, whereby a single resistance
cassette or plasmid acquisition can render a bacterium
resistant against several classes of antimicrobials with a
single acquisition event.
The K. pneumoniae species complex is highly diverse,
with three different species predominating amongst hu-
man, environmental, and animal isolates [7]. K. pneumo-
niae comprises four main lineages: K. pneumoniae
subsp. pneumoniae; K. quasipneumoniae subsp. quasip-
neumoniae and subsp. similipneumoniae; and K. varii-
cola. The vast majority of hospital isolates belong to K.
pneumoniae subsp. pneumoniae (K. pneumoniae sensu
stricto). From whole-genome sequencing studies com-
paring outbreaks of drug-resistant K. pneumoniae in
both well-resourced and poorly resourced healthcare set-
tings [8, 9], it is clear that there are successful high-risk
clones that re-occur in independent settings globally
[10]. In common with K. pneumoniae, E. cloacae
comprises a diverse species complex with recent reclassi-
fication and revision into 18 E. cloacae subspecies
clusters [11].
Whilst it is appreciated that both species are highly di-
verse and multiple lineages and/or clones cause signifi-
cant health burden, it has become clear that we lack a
basic understanding of their population dynamics in
clinical settings. Most studies focus on short time frames
and provide only short glimpses into the population
structure. This significantly limits our understanding of
the change in diversity over time and the dynamic gain
and loss of antimicrobial resistance genes/mutations
over time. To address this, we undertook a 7-year longi-
tudinal study to gain better resolution of the temporal
flux of AMR at the Cambridge University Hospitals
NHS Foundation Trust (CUH), a 1000-bed secondary
and tertiary referral hospital in the UK. We examined
the relative contributions of the bacterial lineage itself
and the mobile AMR determinants towards the temporal
flux in the phenotypic patterns of AMR seen in this set-
ting. To provide the context for the changing patterns of
disease and AMR in CUH, we relate these data to na-
tional AMR surveillance data and global genomic data
for these pathogens. We show that K. pneumoniae line-
ages were successively replaced by new lineages entering
CUH that had acquired ESBLs, such as blaCTX-M-15, and
were disseminated internationally. E. cloacae isolates on
the other hand showed little temporal flux and were
highly diverse, largely unlinked to international spread
and reliant on intrinsic cephalosporin resistance via the
endogenous AmpC enzyme for AMR. Our study high-
lights the need for more mechanistic pathogen-specific
approaches to control antimicrobial resistance and
antimicrobial-resistant bacteria.
Results
Longitudinal patterns of antimicrobial resistance in
K. pneumoniae and E. cloacae
Patient and isolate metadata were collected for the first-
recorded K. pneumoniae isolate cultured from 13,379
patients and the first E. cloacae from 5661 patients at-
tending CUH between 2001 and 2012 (summarized in
Fig. 1). As such, patients at CUH were 2.4 times more
likely to have a positive K. pneumoniae culture com-
pared to E. cloacae during this period. For both species
complexes, the sample types were mainly blood,
followed by urine, wounds, and sputum, although E. clo-
acae were isolated from a wider range of body sites
(arm/leg, groin, breast, pelvic) compared to K. pneumo-
niae (Additional file 1: Figure S1).
Antimicrobial resistance data showed that K. pneumo-
niae isolates had reduced susceptibility to penicillins (as
expected for the species), whilst 6–19% of isolates in a
year were resistant to two of the six antimicrobial groups
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tested (see the “Materials and methods” section; Fig. 1a).
The proportion of K. pneumoniae isolates with pheno-
typic resistance to three or more groups varied consider-
ably over time (3.5 to 24%), with peaks in resistance
occurring in 2006–2007 and 2011–2012 (Fig. 1a). These
peaks were associated with flux in the proportion of
isolates resistant to third-generation cephalosporins or
aminoglycosides (Fig. 1a). For E. cloacae, the background
proportions of antimicrobial resistance were higher, with
66–82% of isolates resistant to at least two of the anti-
microbial groups tested (Fig. 1b). Unlike K. pneumoniae,
multiple peaks in the proportion of isolates resistant to
Fig. 1 Trends in drug resistance amongst K. pneumoniae and Enterobacter spp. isolated from patients attending CUH between 2000 and 2012.
The proportion of a Klebsiella pneumoniae and b Enterobacter spp. resistant to one group of antimicrobials or less (pale shading), two groups
(mid-shading), or three or more groups (dark shading) are shown, and a major change in national antimicrobial prescribing practice in 2007 is
denoted with a red vertical line. Black vertical lines represent 95% confidence intervals. Resistance to cephalosporins and/or aminoglycosides in
K. pneumoniae or aminoglycosides in E. cloacae is shown for isolates from Cambridge alone (dashed white line) and the UK (dotted white lines)
(UK data from www.bsacsurv.org)
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one or more additional groups were seen more often, in
2001, 2004, 2007, and 2012 (Fig. 1b).
The differing trends in proportions of resistant K.
pneumoniae and E. cloacae at CUH mirrored trends in
national surveillance data during the same time period
(71) (Fig. 1). These all had a transient downward trajec-
tory immediately after a change in 2007 to national anti-
microbial prescribing policy that aimed to decrease
cephalosporin usage [12].
K. pneumoniae and E. cloacae at CUH between 2006 and
2012 reflected the wider diversity of the species
To investigate the basis of these different trends between
the species, we selected 162 K. pneumoniae and 132 E.
cloacae isolates from 158 and 132 patients, respectively,
for sequencing. Isolates were collected between 2006
and 2012 from blood and a range of other body sites
(Additional file 1: Figure S1), representing 20–34% of
the total invasive K. pneumoniae and 40–45% of invasive
E. cloacae isolated at CUH, in any year between 2006
and 2012. The isolates included 114 and 92 isolates that
constituted all of the invasive isolates that were resistant
to three or more of the six antimicrobial groups tested
for K. pneumoniae and E. cloacae, respectively, between
2006 and 2012. Since there were no fully susceptible iso-
lates collected during this period, 48 K. pneumoniae and
40 E. cloacae isolates resistant to no more than two anti-
microbial groups were selected at random for inclusion
as a (c. 10%) sub-sample of “susceptible” comparators
(Table 1).
Although all isolates had been classified by the routine
microbiology laboratory as K. pneumoniae, the whole
genome phylogeny of K. pneumoniae revealed other
species within the species complex; 15 isolates were K.
quasipneumoniae or K. variicola (Fig. 2a; Additional
file 1: Figure S2A; Additional file 2: Table S1). Geno-
typic resistance predictions indicated that at CUH,
the other species were not predominated by multi-
drug-resistant isolates (Additional file 1: Figure S3),
emphasizing that by contrast, K. pneumoniae sensu
stricto were the subspecies comprising the majority of
multidrug-resistant isolates.
When combined with a global collection representing
the K. pneumoniae population structure [7] (Fig. 2a,
Additional file 2: Table S2), our phylogeny showed that
the diversity seen at CUH was representative of the glo-
bal population diversity, with all major lineages repre-
sented. This included the relatively rare subspecies: K. q.
subsp. quasipneumoniae, K. q. subsp. similipneumoniae,
and K. variicola (Fig. 2b). Comparison with a UK
collection sampled during a similar time frame [14]
(Additional file 1: Figure S2A; Additional file 2: Table
S3) showed that the CUH K. pneumoniae reflected the
contemporaneous national distributions across the
species complex and the diversity of sequence types
(Additional file 1: Figure S2A).
E. cloacae contained two separate species (E.
aerogenes, recently reclassified as Klebsiella aerogenes
[15], and E. kobei), as well as several subspecies and
clusters. Using the revised E. cloacae taxonomy [11], we
observed high levels of genomic similarity. Clustering
using a distance matrix (mash [13]) at the cutoff of
0.05% which is representative of the species cutoff ANI
0.95% [13] showed a large group comprised of several
previously described subgroups [11] that were resolved
when a finer distance cutoff (0.015) was used (excepting
group G/H; Fig. 3a, Additional file 2: Table S4). The
CUH population diversity was comparable to that ob-
served for isolates from across the UK [16] (Additional
file 1: Figure S3B; Additional file 2: Table S3), but unlike
K. pneumoniae, there were clear differences evident
when compared with the global collection [11] (Fig. 3b,
Additional file 2: Table S5). We identified 8 out of the
18 clusters described previously [11] and discovered two
new clusters nested in the widely distributed E. xianfan-
gensis and E. hormaechei subgroups (Fig. 3a). We also
Table 1 K. pneumoniae and E. cloacae collected in 2006–2012 that underwent whole-genome sequencing
Resistance
to drug
groups
K. pneumoniae isolates (n) E. cloacae isolates (n)
Available
(2006–
2012)
Sequenced Available
(2006–
2012)
Sequenced
2006–2012 Q4 2012 2006–2012 Q4 2012
0 0 0 0 0 0 0
1 279 28 3 24 12 3
2 104 15 2 128 16 9
3 4 4 4 50 44 8
4 29 28 8 2 2 3
5 6 6 5 19 19 14
6 43 43 16 2 2 1
Total 465 124 38 225 95 38
Isolates were stratified according to the number of antimicrobial groups to which they were phenotypically resistant by routine diagnostic testing
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Ellington et al. Genome Biology          (2019) 20:184 Page 5 of 16
observed a far lower percentage of E. xiangfangensis that
expanded with the spread of KPC-type carbapenemases,
which is consistent with our dataset lacking
carbapenem-resistant isolates (Fig. 3b). Analysis of the
deep branching lineages showed E. kobei and E. ludwigii
were exclusively isolated from blood, whereas E. aero-
genes and groups G/H were from a wider variety of
isolation sites, possibly more indicative of opportunistic
infections (Additional file 1: Figure S3C). These
differences were also reflected in the predicted (geno-
typic) resistance profiles, with E. kobeii showing resist-
ance to two or three antimicrobial classes, whereas the
other deep lineages showed no (E. aerogenes, E. ludwigii)
or only a low proportion (groups G/H) of MDR isolates
(Additional file 1: Figure S3D).
K. pneumoniae and Enterobacter represented flowing vs
static populations in CUH between 2006 and 2012
The dominance of four globally important clones (STs: 15;
101; 307; 874) amongst the K. pneumoniae at CUH (41%)
(Additional file 1: Figure S3A; Additional file 2: Table S1)
was led by ST15 which is strongly linked to outbreaks in
hospitals [8, 17, 18]. ST101 has been highlighted for its asso-
ciation with extensive resistance and KPC carbapenemases
[19], and ST307 was reported in a recent large-scale analysis
of carbapenem-resistant isolates [20, 21]. By contrast in E.
cloacae, the main four sequence types constituted only
27% of the isolates (Additional file 1: Figure S3B;
Additional file 2: Table S4), suggestive of different popula-
tion dynamics for these two genera in a hospital setting.
Successive replacements of the K. pneumoniae STs oc-
curred over time (Fig. 4a). Testing for the correlation be-
tween genetic distance using whole-genome SNP data
(after removing recombination) and the date of isolation
showed a strong correlation between phylogenetic signal
and the temporal information, using month, year, and the
observed 2-year span as a trait (Fig. 4b; Additional file 1:
Figure S4). This trend was not apparent for Enterobacter
isolates (Fig. 4b), with all clones represented across the
study period. These temporal signals for strain flow vs stasis
between the species were not perturbed after 2007 when
the change in antimicrobial prescribing policy occurred.
Sharing of the same composite and dynamic resistance
elements differed across the genera
To gain insight into the contrasting population and
resistance dynamics between K. pneumoniae and E.
cloacae, we compared the patterns of genotypic to
phenotypic resistance, i.e., how well-predicted resistance
genes could explain the observed resistance patterns
(Fig. 5a).
For K. pneumoniae, resistance to aminoglycosides, tri-
methoprim, and the beta-lactams was closely linked with
horizontally acquired genes (Fig. 5a; Additional file 1:
Figure S5; Additional file 2: Table S1). Amongst the
beta-lactams, ESBLs were detected in almost all
cephalosporin-resistant isolates (95 out of 99), most
often blaCTX-M-15 (85 isolates). Only three isolates
encoded carbapenemases (Additional file 2: Table S1).
For the same three antimicrobial classes in E. cloacae,
gene presence predicted resistance in 20 out of 33
aminoglycoside-resistant and 33 out of 40 trimethoprim-
resistant isolates (Fig. 5a, Additional file 2: Table S1 and
Table S4). The poor correlation between resistance to
third-generation cephalosporins and the presence of
ESBL genes (30 of 94 resistant isolates acquired ESBL
genes) (Additional file 2: Table S2) in E. cloacae could
be explained by the upregulation of the endogenous
AmpC beta-lactamase [22–29].
Differences are also clearly apparent when assessing
the most dominant STs. Whilst in K. pneumoniae, the
four dominant STs are almost exclusively comprised
of multidrug-resistant isolates, the opposite was true
for E. cloacae (Fig. 5b).
When analyzing co-occurrence of resistance elements,
we noticed that the main resistance cassettes were
shared between K. pneumoniae and E. cloacae and
almost always show perfect co-occurrence (Fig. 6, left
panels). This includes the comparatively few E. cloacae
encoding ESBL genes (blaCTX-M-15), which were identi-
fied with the same pattern of aminoglycoside and tri-
methoprim resistance genes that was found in K.
pneumoniae, indicating both species access the same
shared gene pool, but the distribution across the popula-
tions is clearly different between the two species. To re-
solve this, we performed long-read (PacBio) sequencing
on selected isolates, which confirmed that the resistance
genes shared related genetic environments, suggesting
that both genera were acquiring a similar pool of
resistance genes. However, there is an extensive pool of
mobile elements being sampled, with no two isolates
sharing the same plasmid repertoire (Fig. 6 right panels).
The key ESBL gene blaCTX-M-15 was found integrated at
an array of different chromosomal sites or carried on a
(See figure on previous page.)
Fig. 2 K. pneumoniae isolates from CUH within the global population structure. a Phylogenetic tree reconstruction of the core gene alignment
again highlights the diversity encountered in routine hospital samples. The inner ring shows mash clusters [13] which split the three species K.
pneumoniae, K. quasipneumoniae, and K. variicola, at a cutoff of 0.04 correlating to an ANI of 96%. The outer ring displays which samples are
derived from this study, embedded in the global diversity [7]. b Barplot illustrating the numbers of the different lineages observed in our
collection compared to the global collection [7]
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Fig. 3 E. cloacae isolates from CUH within the global population structure. a Phylogenetic tree reconstruction from the core gene alignment
highlights the diversity encountered in routine hospital samples. The inner and middle rings show the same clustering information at 0.05 and
0.015, respectively. The outer ring displays which samples are derived from this study, embedded in the global diversity [11]. Accession numbers
and cluster annotation are given in Additional file 2: Tables S2 and S5 for the global collection and the samples from this study, respectively.
b Barplot illustrating the numbers of the different lineages observed in our collection compared to the global collection [11]
Fig. 4 Population structures of Klebsiella and Enterobacter over time. a Visualizing the occurrence of the four main sequence types for Klebsiella
(left tree) and Enterobacter (right tree) highlights a consecutive replacement of the different Klebsiella sequence types, whereas the main
Enterobacter sequence types occur continuously as mixed population during all time frames. b Test for the correlation of the distance on the tree
between two samples using SNP data from whole-genome trees after removing recombination and sharing or difference of a trait (2-year spans
of isolation as given in Additional file 2: Tables S1 and S4). This shows a strong positive correlation (similar trait is more likely) for very close strains
and negative correlation (similar traits are more unlikely) for large distances on the tree for Klebsiella (left panel); no signal can be observed for
Enterobacter (right panel)
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diverse set of plasmid replicons in K. pneumoniae and E.
cloacae alike (Fig. 6a, b), with no two strains sharing it
at the same location. A comparison against a curated
large-scale plasmid database showed that these elements
co-occur (Additional file 1: Figure S6), but less fre-
quently as seen in our examples. This is most likely since
similar geographic and temporal isolation sources seem
to reflect a dynamic pool of transposable elements and
plasmids shared between K. pneumoniae and E. cloacae,
and potentially also other members of the Enterobacter-
ales occurring at the same time in the area.
Discussion
WGS highlighted the contrasting AMR populations of
these species in our hospital across 6 years from 2006.
The K. pneumoniae population was dominated by clonal
replacements of major STs with the majority of isolates
multidrug-resistant due to uptake of resistance plasmids
(STs 874, 101 and 307), whilst the E. cloacae hospital
population reflected a continuous sampling from the
whole diversity without temporal signal and without
apparent fitness advantage for strains carrying mobile
elements conferring resistance. For Klebsiella, this
indicated the importance of horizontal acquisition of
ESBLs, like blaCTX-M-15, whilst for Enterobacter, it em-
phasized the capacity for intrinsic cephalosporin resist-
ance via the endogenous AmpC enzyme [30].
We observed four successive introductions of highly
cephalosporin-resistant K. pneumoniae clones. Three of
the four (excepting ST307) are known to be widespread
in the UK [14], and all four have been seen to be
resistant lineages disseminated internationally [20]. In
contrast, for Enterobacter, there were differences be-
tween this cephalosporin resistance-focussed study and a
recent global study. The main difference was due to an
under-representation E. xiangfangensis, a major Entero-
bacter lineage associated with plasmid-acquired KPC-
based carbapenem resistance. This is in accordance with
our sampling time frame, which are derived from times
before carbapenems were widely used, and strongly
indicates that the shift from intrinsic resistance to
advanced cephalosporins (in our study) to relying on
acquired resistance mechanisms for carbapenem
resistance (via plasmid-derived KPC) changed the E.
cloacae population structure towards few dominating
clones, as discussed in [16].
A B
Fig. 5 Different population and resistance profiles in the two data collections. a A comparison of the number of isolates to be resistant according
to the genes as predicted (light bars) and measured to be resistant in physical tests (dark bars). b The distribution of MDR isolates across the
main STs for Klebsiella and Enterobacter spp., with the total number of isolates for the ST in lighter and the number of isolates resistant against all
three classes in darker color
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Fig. 6 The conservation of integrons and mobile units across the species vs the dynamic broader genetic context. The guidance trees are based
on the core gene alignment for Klebsiella pneumoniae (a) and Enterobacter cloacae (b). The conservation of the genetic environment of the main
acquired resistance genes blaCTX-M-15, blaTEM1, blaOXA1, aac(6′)-Ib-cr, and aac(3)-IIa was tested by mapping against the predominantly observed
cassettes surrounding these genes as mobile units. Whilst blaCTX-M-15 moves by itself in the Tn2021 structure, and blaTEM-1 moves with a tnpR
gene, the blaOXA-1, aac(6′)-Ib-cr, and cat (chloramphenicol-resistance) genes are conserved in an integron element and the aac(3)-IIa and tmrB
(tunicamycin resistance) genes are conserved together. This highlights that even though there is high variability in the plasmid content, there is a
core set of resistance gene cassettes that is stable in both populations, and strains very often carry all of them combined. Long-read assemblies
(Pacbio) resolved the plasmid content and location of the CTX-M-15 gene in several representatives of Enterobacter spp. and Klebsiella spp., as
indicated by the arrows to the core gene guide trees. The respective boxes illustrate the plasmid content with the Inc-type and their respective
sizes. The arrow diagrams illustrate the location of the CTX-M-15 gene, which is highly mobile, and can be seen to be integrated into the
chromosomes in three out of our nine examples, each at different locations, as well as on plasmids belonging to the IncR, IncFIB(K)/IncFIIK,
IncHI2/IncHI2A, and IncHIB types
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The finding that small numbers of diverse Enterobacter
acquired the same collection of mobile resistance ele-
ments found across K. pneumoniae demonstrated a simi-
larity between the species in their use of a linked network
of mobile resistance genes, which, based on reports on E.
coli [3], is widely shared with other Enterobacterales. For
this study, the consistent profile of the numerous resist-
ance genes present alongside blaCTX-M-15 detected from
short-read data masked the extensive plasticity and vari-
ability of the complex resistance elements acquired by
both species. Despite this plasticity of different plasmids
and chromosomal integration sites, the presence and ab-
sence of the resistance genes themselves remained stable
across the major K. pneumoniae clones found in 2012
(ST307) or in 2006 (i.e., ST874). The lack of association
between the persistent or successful lineages of E. cloacae
indicated that AMR alone did not explain the success of
major clones in either genus, a point that will form the
basis of ongoing and future work.
Conclusions
We demonstrated the stark contrast of the MDR popula-
tion dynamics between two major pathogens in a major
UK hospital. Whilst cephalosporin resistance in K. pneu-
moniae is plasmid driven, E. cloacae can rely on its
chromosomal resistance mechanism. This leads to a
markedly different population structure and shows that
plasmid-derived resistance leads to the shift from a
highly diverse population to the dominance of a few
major lineages, whilst chromosomal resistance mecha-
nisms do not bias the population, with a similar compos-
ition observed throughout the 7-year time frame.
Materials and methods
Surveillance data for national context
The annual national context for cephalosporin and
aminoglycoside resistance in K. pneumoniae and E. clo-
acae was analyzed using antimicrobial susceptibility data
from the BSAC Bacteraemia Resistance Surveillance
Programme (www.bsacsurv.org, accessed April 2018).
Susceptibility data for gentamicin, cefotaxime, and
ceftazidime from the first seven isolates of both species
collected at each of 30 sentinel laboratories each year
between 2001 and 2012 was included.
Clinical setting, patient data, and isolate collections
Cambridge University Hospitals NHS Foundation Trust
(CUH) is a 1000-bed secondary and tertiary referral hos-
pital. The on-site Public Health England Clinical Micro-
biology Laboratory processes ca. 1,000,000 specimens
per annum for CUH. Linked anonymized patient demo-
graphic and routine microbiology laboratory data (NHS
research ethics committee approval 12/SC/0431), includ-
ing species identifications by API (bioMérieux, Marcy
L’Etoile, France) or MALDI Biotyper (Bruker Daltonics,
Bremen, GmbH) indicated that between 2006 and 2012,
13,379 patients were positive for K. pneumoniae (from
any specimen type) and 5661 patients were positive for
E. cloacae (from any specimen type). We included and
analyzed antimicrobial susceptibility data, determined
according to the BSAC disc diffusion method [31] for
the first isolate of these two species from each patient.
Between 2006 and 2012, K. pneumoniae and/or E.
cloacae associated with invasive disease (isolated via
sterile site cultures) in patients at CUH was stored at −
80 °C. To understand the populations of sensitive and
resistant isolates of each species by WGS, we first strati-
fied the 465 invasive K. pneumoniae and 225 invasive E.
cloacae according to their routine laboratory antimicro-
bial susceptibility results for six groups of antimicrobials
that were tested each year between 2006 and 2012
(penicillins, amoxicillin-clavulanate, aminoglycosides,
fluoroquinolones, trimethoprim, and third-generation
cephalosporins). To enrich for drug-resistant isolates, we
included all of the available invasive isolates that were re-
sistant to three or more groups for both species (Table 1).
From amongst the invasive isolates that were resistant to
two groups of antimicrobials or fewer, we randomly se-
lected 44 K. pneumoniae isolates (11.5% of the available
isolates) and 28 (18.4%) of the available E. cloacae isolates
(Table 1), which for the invasive isolates, represented 20–
34% of K. pneumoniae and 40–45% of E. cloacae isolated
in any year being included for study. Where a patient
had an isolate of both species that was resistant to
three or more groups of antimicrobial, we included
one isolate of both species. Isolates of the same spe-
cies were de-duplicated to represent one isolate per
species per patient except four patients for whom two
isolates of K. pneumoniae were included due to differ-
ences in initial phenotypic susceptibilities that were
considered suggestive of different strain types. From
this collection of invasive isolates, we included 124 K.
pneumoniae from 120 patients and 94 E. cloacae from
94 patients for further study. Additionally, a prospect-
ive collection (during the last half of 2012) of K.
pneumoniae and E. cloacae isolated from samples
taken from any body site yielded a further 38 isolates
of K. pneumoniae and 35 isolates of E. cloacae from a
total of 73 patients. Of these, 33 K. pneumoniae and
26 E. cloacae isolates were resistant to three or more
groups of antimicrobials (Table 1).
Of the isolates included for study, four carbapenemase-
producing E. cloacae were identified by Public Health
England’s (PHE) national Antimicrobial Resistance and
Healthcare Associated Infections (AMRHAI) Refer-
ence Unit to produce IMP-1 carbapenemase (as well
as other co-acquired resistance genes). One K.
pneumoniae was identified later to carry the NDM-1
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carbapenemase gene, one to carry the KPC-2 gene,
and one the CARB-12 gene. In total, 162 K. pneumo-
niae from 158 patients and 133 E. cloacae from 133
patients were sequenced (Additional file 2: Table S1
and S4).
Bacterial culture and antimicrobial susceptibility testing
Clinical specimens had been previously processed ac-
cording to standard operating procedures, including
antimicrobial susceptibility testing using the BSAC disc
diffusion method [31] with results interpreted using
EUCAST breakpoints. For this study, bacteria were
re-identified using MALDI-ToF (Bruker Daltonics)
and antimicrobial susceptibilities confirmed with the
VITEK-2 instrument (BioMérieux). MICs were deter-
mined by agar dilution methodology for three NDM
carbapenemase-producing E. cloacae in Public Health
England’s AntiMicrobial Resistance and Healthcare
Associated Infections (AMRHAI) Reference Unit.
DNA sequencing
Isolates were cultured overnight on Brilliance UTI
chromogenic agar (Oxoid, UK), then inoculated into
Brain Heart Infusion broth (Oxoid, UK) and grown to
stationary phase. DNA was extracted and quantified [8].
Whole-genome sequencing was performed on a HiSeq
2000, and 150 bp paired-end Illumina sequencing reads
were produced [32]. Selected samples were also se-
quenced on a PacBio RSII using P6/C4 sequencing
chemistry. High molecular weight DNA for long-read se-
quencing was prepared from bacterial cultures by
phenol-chloroform extraction from overnight cultures;
phases were separated by centrifugation using MaXtract
phase lock tubes (Qiagen) according to the manufac-
turer’s instructions. Libraries were made using the
SMRTbell Template Prep Kit 1.0. Sequence data have
been deposited in the European Nucleotide Archive
(Additional file 2: Table S1 and S2).
Annotated assemblies of short-read Illumina data were
produced [33]: briefly, for each sample, multiple assem-
blies were created using VelvetOptimiser v2.2.5 [34] and
Velvet v1.2 [35], assembly improvement using the best
N50 and contigs in scaffolds via SSPACE [36] was
followed by sequence gap filling using GapFiller [37].
For PacBio, sequence reads were assembled using Canu
(v1.1) [38] with filtered subreads generated through the
SMRT analysis software v2.3.0. Assemblies were circu-
larized using Circlator v1.1.3 [39] using the corrected
reads generated during the Canu assembly. Finally, the
circularized assembly was polished with the short-reads
and pilon as implemented in the unicycler-polish script
[40]. If not all resulting contigs were circularized, assem-
blies combining the Illumina and PacBio reads were
performed using unicycler [40], followed by Circulator
with the corrected reads generated in the previous Canu
assembly, and unicycler-polish. The assemblies used
were based on Canu for Kpn135, Kpn23, Kpn27, Kpn56,
Kpn81, Kpn98, Ecl21, and Ecl55; the hybrid assembly
was used for Kpn16 and Ecl130. All assemblies were
controlled by mapping back the PacBio and Illumina
reads of the respective strain using bwa mem (default
options; -x pacbio for the pacbio reads), as well as
Mauve alignments of the Illumina assemblies to the final
assemblies. Automated annotation of all assemblies was
performed using PROKKA v1.11 [41] and genus-specific
databases from RefSeq [42].
Sequence analyses
Multi-locus sequence typing was performed using blast
against the sequence types available at PubMLST [43].
The resistance gene content and plasmid replicon types
carried by each isolate were predicted using the short-
read search software ariba [44] with the implemented
arg-annot as provided for SRST2 [45, 46] and Plasmid-
Finder [47] databases respectively. K. pneumoniae cap-
sule and O-antigen type was predicted using Kaptive
[48], using the capsule type database provided with
Kaptive and an in-house generated database based on
the different O-antigen operons described [49]
(Additional file 2: Table S2); the distinction between
different O-types was revised according to the
recently published updated typing online platform
(http://kaptive.holtlab.net) [50].
We combined our K. pneumoniae and E. cloacae datasets
with a global collection and a UK-focused collection (Add-
itional file 2: Table S3), for each species [7, 11, 14, 16].
Roary [51] was used to determine the core, soft core, and
shell components of the pan-genome for the respective
datasets (Additional file 2: Tables S1 - S5). For core gene
tree-based phylogeny, the core gene alignment from roary
was retrieved and informative sites were chosen using snp_
sites [52] and trimal [53] as detailed in the respective figure
legends, and RAxML (v 8.2.8) was used to construct phylo-
genetic trees using the general time-reversible (GTR)
model with 100 bootstrap support calculations. iTOL was
used for tree and metadata visualization [54]. Clustering
was performed using mash (as an approximation of ANI
[13]), and cutoffs were chosen as indicated in the figure
legend (Fig. 3). Reference sequences for the mash cluster-
ing to define (sub)species and further groups were used as
given in Additional file 2: Table S5. (Pro)Phages in the
PacBio assemblies were predicted using Phaster [55].
Bacteria mapping and variant detection
For each sample of K. pneumoniae or E. cloacae,
sequence reads were mapped against the reference gen-
ome (Enterobacter hormaechei subsp. steigerwaltii DSM
16691, Genbank accession CP017179.1, for Enterobacter;
Ellington et al. Genome Biology          (2019) 20:184 Page 12 of 16
K. pneumoniae subsp. pneumoniae MGH 78578,
Genbank accession CP000647.1, for Klebsiella) using
SMALT v0.7.4 [56, 57] to produce a BAM file. Variation
detection was performed using SAMtools mpileup
v0.1.19 [58] with parameters “-d 1000 -DSugBf” and
bcftools v0.1.19 [59] to produce a BCF file of all variant
sites. The option to call genotypes at variant sites was
passed to the bcftools call. All bases were filtered to re-
move those with uncertainty in the base call. The
bcftools variant quality score was required to be greater
than 50 (quality < 50) and mapping quality greater than
30 (map_quality < 30). If not all reads gave the same
base call, the allele frequency, as calculated by bcftools,
was required to be either 0 for bases called the same as
the reference, or 1 for bases called as a SNP (af1 < 0.95).
The majority base call was required to be present in at
least 75% of reads mapping at the base (ratio < 0.75), and
the minimum mapping depth required was 4 reads, at
least two of which had to map to each strand (depth < 4,
depth_strand < 2). Finally, strand_bias was required to
be less than 0.001, map_bias less than 0.001, and tail_
bias less than 0.001. If any of these filters were not met,
the base was called as uncertain.
A pseudo-genome was constructed by substituting the
base call at each site (variant and non-variant) in the BCF
file into the reference genome, and any site called as un-
certain was substituted with an N. Insertions with respect
to the reference genome were ignored, and deletions with
respect to the reference genome were filled with N’s in the
pseudo-genome to keep it aligned and the same length as
the reference genome used for read mapping. Gubbins
[57] was then used to remove recombinant/highly variable
regions from the alignment, and the resulting reduced
alignment was used as input for tree calculations as well
as pairwise SNP comparisons. These were performed with
the dist.alignment() function in the R package seqinr [60],
which gives relative values and therefore enables plotting
both organisms onto one y-axis. We tested for relative
enrichment of organisms of the same sequence type vs.
different sequence type in the same or different 2-year
time span using the chi.square() function as implemented
in R (v3.4.2). The contingency matrix consisted of num-
bers of isolates of same vs. different ST occurring in the
same vs. different 2-year span, which was significant
for K. pneumoniae and not significant for E. cloacae
(p values < 2.2e−16 and p = 0.03, respectively).
The masked alignment was used as input for phylo-
genetic tree calculation using RAxML as described
above, disregarding positions with more than 5% N con-
tent, to perform tests for phylogenetic signal, where 10
maximum likelihood trees were generated as described
above. For branch length comparisons and testing for
phylogenetic signal, we used the phylosignal package in
R and calculated correlation plots using either month,
year, or 2-year span as trait information [61]. To ensure
that enough signal is in these three traits, for each cor-
relation, we also performed a randomization step using
the sample() function in R. All tree files and alignments
as well as the R script used to assess phylogenetic signal,
SNP distances, and the chi-square test are available for
download at the figshare link [https://figshare.com/s/83
0209f84c587c28813e].
Plasmid/integron analyses
Pacbio plasmids were annotated using the online plas-
midfinder database to annotate the assembled sequences.
The integron/mobile cassette sequence(s) were identified
manually by searching for the main beta-lactam and
aminoglycoside resistance conferring genes (blaOXA,
blaCTX, blaTEM, aac(3)IIa, aac(6′)-Ib-cr), and annotation
was performed by using the ISFinder resource [62] as
well as blast against the non-redundant genbank data-
base [63, 64]. Annotating the identified mobile units in
the Illumina samples was performed by blasting the
DNA sequences derived from pacbio against the Illu-
mina assemblies with an e value cutoff of 1e−90; partial
hits were identified as encoding the respective resistance
genes, but truncated mobile elements due to frameshifts
or other elements inserting within them. Comparison of
the operons was depicted using GenePlotR [65] with the
respective closest reference contigs as templates; repli-
cons were identified using the plasmidfinder resource as
described above. For a comparison against the plasmid
database, the assemblies of the database were down-
loaded (16. 04. 2019; https://doi.org/10.15146/R33X2J)
[66], and blast runs performed using the same elements
as in the ariba search as input. To account for less
closely related organisms, we accepted hits with over
99% similarity. If several hits of the same cassette on one
plasmid were reported, the longest element was chosen;
if two elements were still of the same length, the elem-
ent with the higher similarity was chosen; if this still did
not distinguish the hits, the first one in the sequence
was chosen for representation. The plasmids were
clustered using the heatmap.2() command in R using the
percentage of similarity to the different cassettes as data
matrix for clustering. The region of coverage on the
cassettes was displayed using the ggtree package and the
facetplot function in R [67].
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